0001140361-21-042237.txt : 20211217 0001140361-21-042237.hdr.sgml : 20211217 20211217164137 ACCESSION NUMBER: 0001140361-21-042237 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210817 FILED AS OF DATE: 20211217 DATE AS OF CHANGE: 20211217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tilray, Inc. CENTRAL INDEX KEY: 0001731348 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-56199 FILM NUMBER: 211502183 BUSINESS ADDRESS: STREET 1: 655 MADISON AVENUE STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10065 BUSINESS PHONE: 519.322.8800 MAIL ADDRESS: STREET 1: 655 MADISON AVENUE STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10065 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MedMen Enterprises, Inc. CENTRAL INDEX KEY: 0001776932 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-RETAIL STORES, NEC [5990] IRS NUMBER: 981431779 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 10115 JEFFERSON BOULEVARD CITY: CULVER CITY STATE: CA ZIP: 90232 BUSINESS PHONE: 4243302082 MAIL ADDRESS: STREET 1: 10115 JEFFERSON BOULEVARD CITY: CULVER CITY STATE: CA ZIP: 90232 3 1 form3.xml FORM 3 X0206 3 2021-08-17 0 0001776932 MedMen Enterprises, Inc. MMNFF 0001731348 Tilray, Inc. 655 MADISON AVENUE SUITE 1900 NEW YORK NY 10065 true Convertible Note 0.1529 2021-08-17 2028-08-17 Class B Subordinate Voting Shares 20857737.28 I See Footnote Convertible Note 0.17 2021-08-17 2028-08-17 Class B Subordinate Voting Shares 26263572.01 I See Footnote Convertible Note 0.34 2021-08-17 2028-08-17 Class B Subordinate Voting Shares 24387602.58 I See Footnote Convertible Note 0.1529 2021-08-17 2028-08-17 Class B Subordinate Voting Shares 89830505.79 I See Footnote Convertible Note 0.17 2021-08-17 2028-08-17 Class B Subordinate Voting Shares 113112459.23 I See Footnote Convertible Note 0.34 2021-08-17 2028-08-17 Class B Subordinate Voting Shares 105032997.86 I See Footnote Convertible Note 0.1529 2021-08-17 2028-08-17 Class B Subordinate Voting Shares 29211057.26 I See Footnote Convertible Note 0.17 2021-08-17 2028-08-17 Class B Subordinate Voting Shares 36781875.98 I See Footnote Convertible Note 0.34 2021-08-17 2028-08-17 Class B Subordinate Voting Shares 34154599.12 I See Footnote Convertible Note 0.1529 2021-08-17 2028-08-17 Class B Subordinate Voting Shares 21353535.67 I See Footnote Convertible Note 0.17 2021-08-17 2028-08-17 Class B Subordinate Voting Shares 26887869.68 I See Footnote Convertible Note 0.34 2021-08-17 2028-08-17 Class B Subordinate Voting Shares 24967307.56 I See Footnote Convertible Note 0.1529 2021-08-17 2028-08-17 Class B Subordinate Voting Shares 11311119.62 I See Footnote Convertible Note 0.17 2021-08-17 2028-08-17 Class B Subordinate Voting Shares 14242695.68 I See Footnote Convertible Note 0.34 2021-08-17 2028-08-17 Class B Subordinate Voting Shares 13225360.28 I See Footnote Convertible Note 0.1529 2021-08-17 2028-08-17 Class B Subordinate Voting Shares 111596680.65 I See Footnote Convertible Note 0.1529 2021-08-17 2028-08-17 Class B Subordinate Voting Shares 14931229.66 I See Footnote Convertible Note 0.2845 2021-08-17 2028-08-17 Class B Subordinate Voting Shares 5365563.91 I See Footnote Convertible Note 0.1529 2021-08-17 2028-08-17 Class B Subordinate Voting Shares 28874592.48 I See Footnote Convertible Note 0.1608 2021-08-17 2028-08-17 Class B Subordinate Voting Shares 53395928.68 I See Footnote The convertible notes and warrants are owned directly by Superhero Acquisition L.P. ("LP"). Superhero Acquisition Corp. ("Corp.") is the general partner of LP. Tilray, Inc. ("Tilray") owns approximately two-thirds of the outstanding equity interests in Corp. and approximately two-thirds of the outstanding equity interest in LP. Accordingly, for purposes of Rule 13d-3 under the Securities Exchange Act of 1934, as amended, Tilray may be deemed a beneficial owner with respect to securities held of record by LP and has shared voting and investment power with respect to such securities. Tilray disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. This Form 3 is one of two Form 3s filed relating to the same event. This Form 3 has been split into two filings because there are more than 30 derivative securities beneficially owned, and the SEC's EDGAR filing system limits a single Form 3 to a maximum of 30 rows per table. This filing relates to transactions that occurred on August 17, 2021, which were previously disclosed by Tilray in its Current Report on Form 8-K filed on August 18, 2021. As of the date of this filing, Tilray has not executed any transactions in MedMen Enterprises, Inc. securities since August 17, 2021. /s/ Mitchell Gendel, authorized officer 2021-12-17